![N-{[(5S)-3-(3-fluoro-4-morpholin-4-ylphenyl)-2-oxo-1,3-oxazolidin-5-yl]methyl}acetamide in PDB entry 3dll, assembly 1, side view.](https://www.ebi.ac.uk/pdbe/static/entry/3dll_entity_32_side_image-200x200.png "Hetero 30-meric assembly 1 of PDB entry <span class='highlight'>3dll</span> contains 1 copy of <span class='highlight'>N-{[(5S)-3-(3-fluoro-4-morpholin-4-ylphenyl)-2-oxo-1,3-oxazolidin-5-yl]methyl}acetamide</span>. Side view.")
![N-{[(5S)-3-(3-fluoro-4-morpholin-4-ylphenyl)-2-oxo-1,3-oxazolidin-5-yl]methyl}acetamide in PDB entry 3dll, assembly 1, top view.](https://www.ebi.ac.uk/pdbe/static/entry/3dll_entity_32_top_image-200x200.png "Hetero 30-meric assembly 1 of PDB entry <span class='highlight'>3dll</span> contains 1 copy of <span class='highlight'>N-{[(5S)-3-(3-fluoro-4-morpholin-4-ylphenyl)-2-oxo-1,3-oxazolidin-5-yl]methyl}acetamide</span>. Top view.")
Environment details NEW
ZLD 2911 bound to chain X
The above 2D and 3D (Mol*) views of ligand interactions use quaternary structure derived from the PDB entry.
Please note:
Please note:
- Some chain IDs in the tooltip are followed by a number in square brackets. This number corresponds to the operation ID (mmCIF ‘oper_expression’) used to transform the chain.
- The structure seen in Mol* (3D view) was protonated using ChimeraX.
- Interactions were calculated using Arpeggio (see details for interaction types).
- The colour scheme used is consistent with Clustal X.